• Exchange: NASDAQ GS
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Biotech

Pharmacyclics Inc

+ Add to Watchlist

PCYC:US

89.7500 USD 0.2900 0.32%

As of 20:10:00 ET on 04/17/2014.

Company Profile for Pharmacyclics Inc (PCYC)

Pharmacyclics, Inc. is a clinical-stage biopharmaceutical company focused on discovering and developing innovative small-molecule drugs for the treatment of cancer and immune mediated diseases. The Company's pharmaceutical drug development candidates are synthetic small-molecules designed to target key biochemical pathways involved in human diseases with critical unmet needs.

Contact Information

Pharmacyclics Inc

995 East Arques Avenue
Sunnyvale, CA 94085-4521
United States
Phone: 1-408-774-0330
Fax: 1-408-774-0340

Key Executives for Pharmacyclics Inc (PCYC)

Robert W Duggan "Bob"Chairman/CEOManmeet SoniChief Financial Officer
Mahkam Zanganeh "Maky"Chief Operating OfficerJesse McGreivyChief Medical Officer
Maria FardisChief:Oncology Ops & AlliancesHeow TanChief:Quality Technical Ops
Paula S BoultbeeExecutive VP:Sales & MarketingRainer M Erdtmann "Ramses"Senior VP:Investor Relations
Richard Love "Rick"VP/Secretary/General CounselMatthew D OuttenVP:Commercial Operations

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Advertisements
Advertisement
sec ||= nil